During the past decade, HonorHealth conducted 112 clinical trials. In the 10-year time frame, 112 clinical trials started and 42 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 64 clinical trials started and 30 clinical trials were completed. i.e. 46.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "HonorHealth" #1 sponsor was "Abbott Medical Devices" with 15 trials, followed by "Pfizer" with 10 trials sponsored, "Daiichi Sankyo, Inc." with 3 trials sponsored, "Gilead Sciences" with 3 trials sponsored and "Nektar Therapeutics" with 3 trials sponsored. Other sponsors include 111 different institutions and companies that sponsored additional 106 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "HonorHealth" #1 collaborator was "Bristol-Myers Squibb" with 4 trials as a collaborator, "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Daiichi Sankyo, Inc." with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Medivation, Inc." with 2 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "HonorHealth" are "Coronary Artery Disease" (13 trials), "Ovarian Cancer" (13 trials), "Advanced Solid Tumors" (10 trials), "Melanoma" (8 trials) and "Pancreatic Cancer" (7 trials). Many other conditions were trialed in "HonorHealth" in a lesser frequency.

Most popular intervention types in "HonorHealth" are "Drug" (97 trials), "Device" (34 trials), "Biological" (18 trials), "Other" (10 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Pembrolizumab" (6 trials), "Nivolumab" (5 trials), "Paclitaxel" (4 trials) and "Absorb BVS" (2 trials). Other intervention names were less common.

The vast majority of trials in "HonorHealth" are 140 trials for "All" genders, 6 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "HonorHealth". undefined are not yet recruiting, 34 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 68 completed trials in HonorHealth, undefined suspended trials, and 22 terminated clinical trials to date.

Out of the total trials that were conducted in HonorHealth, 70 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 26 trials that are defined as “Not Applicable".